z-logo
open-access-imgOpen Access
Performance of CURB-65, PSI, and APACHE-II for predicting COVID-19 pneumonia severity and mortality
Author(s) -
Junnian Chen,
Bang Liu,
Houwei Du,
Hailong Lin,
Cunrong Chen,
Shanshan Rao,
Ranjie Yu,
Jingjing Wang,
Zhiqiang Xue,
Yixian Zhang,
Yanghuang Xie
Publication year - 2021
Publication title -
european journal of inflammation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.219
H-Index - 20
eISSN - 2058-7392
pISSN - 1721-727X
DOI - 10.1177/20587392211027083
Subject(s) - covid-19 , pneumonia , apache ii , medicine , pneumonia severity index , severity of illness , receiver operating characteristic , mortality rate , community acquired pneumonia , outbreak , pathology , intensive care unit , disease , infectious disease (medical specialty)
No prognostic tools for the prediction of COVID-19 pneumonia severity and mortality are available. We explored whether CURB-65, PSI, and APACHE-II could predict COVID-19 pneumonia severity and mortality. We included 167 patients with confirmed COVID-19 pneumonia in this retrospective study. The severity and 30-day mortality of COVID-19 pneumonia were predicted using PSI, CURB-65, and APACHE-II scales. Kappa test was performed to compare the consistency of the three scales. There was a significant difference in the distribution of the scores of the three scales ( P < 0.001). Patients with PSI class ⩽III, CURB-65 ⩽1, and APACHE-II-I all survived. The ROC analysis showed the areas under the curve of the PSI, CURB-65, and APACHE-II scales were 0.83 (95% CI, 0.74–0.93), 0.80 (95% CI, 0.69–0.90), and 0.83 (95% CI, 0.75–0.92), respectively. Our findings suggest that PSI and CURB-65 might be useful to predict the severity and mortality of COVID-19 pneumonia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom